Member Info for JBongo

I dont think it would be an issue getting lost among third party tests in supermarkets. Its not like they're full of health testing kits. I would also hope that we would have some sort of exclusivity agreement with any companies, with us being their only health kit provider.

Penny also made it clear in the recent presentation that we're not going to go down the direct marketing/sales route as it's so expensive. We'd burn through our millions in no time, and very possibly not make much revenue (we've seen that the DNA test on Amazon are doing sweet FA) Whereas with supermarkets or pharmacy chains, they already have the footfall and loyal customers (and like with the Tesco story, will often get free advertising in the way of newspaper articles if they launch new products). I agree with Penny that we should use that to our advantage.

Agree that ISO accreditation is always a good thing. Possibly something that Boots or Lloyd's have requested from us??

There aren't any shorts open on MHC according to LSE, so there can't be a short squeeze

I'm at about a 50% loss currently. The consolidation won't impact that though. I'll just have 15x fewer shares that are each worth 15x as much.

Bear in mind this share shot up to nearly 7p on covid speculation. It could fly again when we get news of the companies we're linking up with.

It's the actual number of shares that get divided by 15. The 15p I was talking about was just a very rough 1p current price X 15 (mainly rough as I forgot the SP had moved up 20% or so the last couple of weeks...).

So you'd have 24000/15 = 1600 shares after the consolidation.

I think if anything it shows indifference towards the consolidation. Or just that people are at work.

I would say the benefit is that the share price will be around 15p, so it doesn't have the negative connotation of being a penny stock. This can make people more willing to buy.

Negative to me is that 1p is quite a strong psychological barrier. The stock seems to struggle to go below 1p. Whereas 15p isn't as much of a mental block, so the share could fall more if there is a continued lack of news.

I'll vote for it, but not overly fussed either way.

P.s. having less shares wouldn't really affect you as the total number of shares is getting lowered as well, so you still own the same percentage of the overall company.

I've had a look at newfoundlands kit line up compared to ours:

Newfoundland:
Male fertility
Bowel health
Menopause
TSH Thyroid
Ferritin
Vit d
Microalbuminuria
On their website, but not stocked in tesco - kidney health
Coming soon - HIV, UTI and Prostate health

MHC (from recent presentation)
Menopause
Thyroid
Bowel health
Sperms concentration
Vit d
TSH thyroid
Ferritin
Then the kits that newfoundland don't have:
PCOS
female sexual health
General health test
Vitamins and minerals profile
Cholesterol
Heart profile
Weight management
Energy profile
Male sexual health
Erectile dysfunction
Stomach ulcer
DNA tests - heart, vitamins, weight, intolerances, glucose

So we have a better range of products. Although missing one or two that newfoundland have/are working on, such as the HIV and the Microalbuminuria tests. I would say our packaging is also a lot more attractive than the newfoundland kits.

I notice in the mail today that Tesco have launched an at home testing range of kits by a company called newfoundland. That's one boat missed for MHC. Hopefully gives other companies like boots a kick up the bum to get ours launched.

https://mol.im/a/11976131

Or because intrusive can't post anything without swearing at people...

The most interesting bit of the written Q&A on investormeets was this answer:

"The names of the test are available in the presentation, but more detail around the tests will be available when our retail partners launch their at-home testing services and these will be available on our website at the same time."

"When our retail partners launch their at home testing service". This makes it sound like something boots and/or Lloyd's will be pushing a lot as their own service, more than a product which they just have on their website (like mylotus) and don't really promote. It also makes it sound like it's close and more of a 'when', not 'if".

As for your SP question happy, I'll guess 60p in 5 years (taking into account the 15:1 share consolidation)

No problem.

There's also been an update to the Q&A tab today with quite a few additional questions been answered. Nothing overly amazing, but interesting nonetheless.

https://www.investormeetcompany.com/investor/meeting/preliminary-results-for-the-year-ended-31-december-2022

It's in here. You'll have to sign up (free) first though if you're not already a member:

https://www.investormeetcompany.com/investor/company/myhealthchecked-plc#archived

Finally got round to listening to the investor meets presentation. Penny all but confirmed we are going to be launching the new kits (which looked an impressive range) in some major retailers and that they are just doing some last bits of due diligence. This is the correct strategy IMO and we will sell far more than just having them on our own website and spending millions on marketing them. Far easier to just have them on a shelf and boots and let them do the hard work.

We just need patience until the announcements are made. I'll be topping up soon as I can see the share price flying when the RNS drops.

True lolly, but I see that as more of an inconvenience than the doomsday scenario that some are painting.

They could also ask shareholders to up the limit. After all, the limit is a self imposed one, not regulatory.

I don't really understand the worry about the 30% limit on unlisteds. This limit only applies when the purchase(s) are made. The unlisted portion can therefore grow naturally (or the listed portion shrink naturally) to be over 30% of the portfolio no problem. No fire sale required.

Decent results in my eyes. Revenue still growing and cash on the books means no dilutions coming up.

I'm assuming close to 0 sales of the new wellness tests unless told otherwise. Liking forward to seeing who we get the products stocked with. Could be a big BOOM moment later in the year if we get a few RNSs in close succession saying we're going to be physically stocked in boots, Lloyd's, various supermarket's etc. That will drive growth and increase our margins again.

Not sure if the share consolidation will reduce the bid offer spread, but nice that they're thinking about that.

No, that's why you filter them (as all companies do in these types of meetings). Answer the ones you can in the call and the ones you can't later.

Yeah because I'm sure for there's no way for the company to filter them NGR... dear me.

It would be nice if the company actually explained this to us though.

Whole lot of not much really. Commercialisation feels a bit like the number 0 and we're trying to get there by continously dividing a number by 2... Getting closer, but we never quite make it there.

Hope people have been sending their questions in via the investor meets platform. I'm sure most of the questions won't even be asked, but it should be an interesting listen anyway!

By ensuring there is a nice pot of money to pay his vastly inflated (for a company of that size) salary for years to come maybe?